Company intelligence / Profile preview

Neurolutions

Van Nuys, California, United Statesneurolutions.com ↗

Ownership: Private
Development stage: Other

Overview

Neurolutions developed the IpsiHand, an FDA-cleared non-invasive brain-computer interface system for at-home upper extremity rehabilitation in chronic stroke survivors. Clinical studies showed about 70% of participants improved arm and hand movement, with an average improvement of +8.1 points on the Fugl-Meyer Assessment after three months. The device is covered by most insurers and Medicare on a case-by-case basis. Real-world evidence supports significant functional gains for many users over time.

Therapeutic areas: Neurology
Modalities: DeviceBrain-computer interface (BCI)Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Ascension Health VenturesIncept LLCKandu Health (merger partner)

Beyond the preview

Go deeper on Neurolutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurolutions.

Explore the full profile